Spreadsheet: 7e93ea5c-3aeb-4753-b523-74d61a3a3a43
Sheet: Sheet1

Table S1 - Ingenuity Pathway Analysis of the 33 skipped exon events found to be differentially regulated by qPCR | Unnamed: 1 | Unnamed: 2 | Unnamed: 3
Ingenuity Canonical Pathways | -log(p-value) | Ratio | Molecules
Galactose Metabolism | 2.63E00 | 5.26E-02 | GALE,GAA
ILK Signaling | 2.34E00 | 1.65E-02 | VEGFA,FLNA,ACTN1
Ubiquinone Biosynthesis | 2.16E00 | 3.03E-02 | PRMT1,NDUFS2
VEGF Signaling | 1.95E00 | 2.2E-02 | VEGFA,ACTN1
[NAME] Metabolism | 1.82E00 | 1.25E-01 | GALE
Mitochondrial Dysfunction | 1.58E00 | 1.5E-02 | NDUFS2,CASP8
Granzyme B Signaling | 1.52E00 | 6.25E-02 | CASP8
[NAME] in Eukaryotes | 1.52E00 | 5E-02 | [NAME] (includes EG:26909)
RAR Activation | 1.39E00 | 1.15E-02 | VEGFA,PRMT1
Aminophosphonate Metabolism | 1.35E00 | 4.17E-02 | PRMT1
Tumoricidal Function of Hepatic Natural Killer Cells | 1.35E00 | 4.17E-02 | CASP8
Pentose Phosphate Pathway | 1.27E00 | 3.45E-02 | PGD
[NAME] | 1.21E00 | 2.7E-02 | CASP8
Inhibition of Angiogenesis by TSP1 | 1.21E00 | 3.03E-02 | VEGFA
Cell Cycle Regulation by BTG Family Proteins | 1.19E00 | 2.78E-02 | PRMT1
Selenoamino Acid Metabolism | 1.19E00 | 2.86E-02 | PRMT1
Role of PKR in Interferon Induction and Antiviral Response | 1.13E00 | 2.27E-02 | CASP8
Role of RIG1-like Receptors in Antiviral Innate Immunity | 1.12E00 | 2.22E-02 | CASP8
[NAME] | 1.07E00 | 1.96E-02 | CASP8
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells | 1.05E00 | 1.92E-02 | CASP8
Histidine Metabolism | 1.05E00 | 2.04E-02 | PRMT1
Chondroitin Sulfate Biosynthesis | 1.04E00 | 2E-02 | SULT1C2
Cysteine Metabolism | 1.04E00 | 2E-02 | SULT1C2
Keratan Sulfate Biosynthesis | 1.03E00 | 1.96E-02 | SULT1C2
CD27 Signaling in Lymphocytes | 1.03E00 | 1.82E-02 | CASP8
Glutathione Metabolism | 1.02E00 | 1.89E-02 | PGD
Myc Mediated Apoptosis Signaling | 9.79E-01 | 1.67E-02 | CASP8
Death Receptor Signaling | 9.79E-01 | 1.61E-02 | CASP8
Induction of Apoptosis by HIV1 | 9.72E-01 | 1.59E-02 | CASP8
Retinoic acid Mediated Apoptosis Signaling | 9.72E-01 | 1.64E-02 | CASP8
Starch and Sucrose Metabolism | 9.39E-01 | 1.56E-02 | GAA
[NAME] in the Cardiovascular System | 9.33E-01 | 1.52E-02 | VEGFA
Tyrosine Metabolism | 9.2E-01 | 1.49E-02 | PRMT1
Renal Cell Carcinoma Signaling | 9.08E-01 | 1.41E-02 | VEGFA
Caveolar-mediated Endocytosis Signaling | 8.91E-01 | 1.23E-02 | FLNA
Androgen and Estrogen Metabolism | 8.91E-01 | 1.39E-02 | PRMT1
Nitric Oxide Signaling in the Cardiovascular System | 8.8E-01 | 1.23E-02 | VEGFA
Bladder [NAME] | 8.15E-01 | 1.11E-02 | VEGFA
Apoptosis Signaling | 8.1E-01 | 1.09E-02 | CASP8
Virus Entry via Endocytic Pathways | 8.06E-01 | 1.09E-02 | FLNA
Amyotrophic Lateral Sclerosis Signaling | 7.71E-01 | 1E-02 | VEGFA
[NAME] | 7.63E-01 | 9.09E-03 | ACTN1
HIF1α Signaling | 7.55E-01 | 9.71E-03 | VEGFA
Pancreatic Adenocarcinoma Signaling | 7.4E-01 | 8.77E-03 | VEGFA
Role of Tissue Factor in Cancer | 7.36E-01 | 9.26E-03 | VEGFA
Type I Diabetes Mellitus Signaling | 7.33E-01 | 8.77E-03 | CASP8
Corticotropin Releasing Hormone Signaling | 7.25E-01 | 8.62E-03 | VEGFA
Tryptophan Metabolism | 7.22E-01 | 9.09E-03 | PRMT1
Sphingosine-1-phosphate Signaling | 7.15E-01 | 8.4E-03 | CASP8
Ovarian Cancer Signaling | 6.54E-01 | 7.25E-03 | VEGFA
[NAME] | 6.48E-01 | 6.94E-03 | VEGFA
Oxidative Phosphorylation | 6.48E-01 | 7.52E-03 | NDUFS2
Hepatic Fibrosis / Hepatic Stellate Cell Activation | 6.37E-01 | 7.14E-03 | VEGFA
[NAME] Junction Signaling | 5.88E-01 | 6.29E-03 | ACTN1
Aldosterone Signaling in Epithelial Cells | 5.88E-01 | 6.21E-03 | DNAJC21
NF-κB Signaling | 5.71E-01 | 5.88E-03 | CASP8
Endothelin-1 Signaling | 5.67E-01 | 5.99E-03 | CASP8
[NAME] | 5.54E-01 | 5.62E-03 | VEGFA
Ephrin Receptor Signaling | 5.54E-01 | 5.15E-03 | VEGFA
[NAME] Junction Signaling | 5.45E-01 | 5.41E-03 | ACTN1
[NAME] | 5.41E-01 | 5.43E-03 | VEGFA
NRF2-mediated Oxidative Stress Response | 5.39E-01 | 5.32E-03 | DNAJC21
Clathrin-mediated Endocytosis Signaling | 5.33E-01 | 5.29E-03 | VEGFA
Leukocyte Extravasation Signaling | 5.23E-01 | 5.29E-03 | ACTN1
LPS/IL-1 Mediated Inhibition of RXR Function | 5.1E-01 | 4.88E-03 | SULT1C2
[NAME] | 5.08E-01 | 4.88E-03 | ACTN1
[NAME] | 4.88E-01 | 4.44E-03 | ACTN1
Huntington's Disease Signaling | 4.73E-01 | 4.39E-03 | CASP8
Colorectal Cancer Metastasis Signaling | 4.41E-01 | 4.1E-03 | VEGFA
Xenobiotic Metabolism Signaling | 4.11E-01 | 3.8E-03 | SULT1C2
Protein Ubiquitination Pathway | 4.05E-01 | 3.72E-03 | DNAJC21
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis | 3.69E-01 | 3.19E-03 | VEGFA
[NAME] A Signaling | 3.56E-01 | 3.23E-03 | FLNA
Molecular Mechanisms of Cancer | 3.23E-01 | 2.78E-03 | CASP8
Axonal Guidance Signaling | 2.77E-01 | 2.37E-03 | VEGFA
G-Protein Coupled Receptor Signaling | 2.01E-01 | 1.92E-03 | [NAME]